At GBT, we collaborate with academic centers to present and publish key results at medical conferences and in peer-reviewed publications. For additional information related to our data presentations and publications, please contact 1-833-GBT-4YOU (1-833-428-4968) or visit GBTMedInfo.com.
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease
JAMA Network Open, Lubeck et al, November 2019
Treating sickle cell disease by targeting HbS polymerization
Blood, Eaton and Bunn, May 2017
Sickle Cell Disease
New England Journal of Medicine, Piel et al, April 2017
Sickle cell disease: Its molecular mechanism and the one drug that treats it
International Journal of Biological Macromolecules, Ferrone F., December 2016
The delay time in sickle cell disease after 40 years: A paradigm assessed
American Journal of Hematology, Ferrone F., May 2015
Therapeutic Strategies to Alter the Oxygen Affinity of Sickle Hemoglobin
Hematology/Oncology Clinics of North America, Safo M. and Kato G., April 2014
Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin
British Journal of Haematology, Ngo et al, October 2011
Fetal hemoglobin in sickle cell anemia
Blood, Akinsheye et al, March 2011
Induction of Fetal Hemoglobin in Sickle Cell Disease
Blood, Bunn F., March 1999
Pathogenesis and Treatment of Sickle Cell Disease
New England Journal of Medicine, Bunn F., September 1997
Delay Time of Hemoglobin S Polymerization Prevents Most Cells from Sickling in Vivo
Science, Mozzarelli et al, July 1987
